(Q33877072)

29 July 2017

1 reference

title

Developments and improvements in the manufacturing of human therapeutics with mammalian cell cultures (English)

1 reference

29 July 2017

Hesse F

1

1 reference

29 July 2017

Wagner R

series ordinal

2

1 reference

29 July 2017

language of work or name

1 reference

1 April 2000

1 reference

29 July 2017

published in

Trends in Biotechnology

1 reference

29 July 2017

volume

18

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

173-180

1 reference

First MAb approved for treatment of metastatic breast cancer.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

The serial cultivation of human diploid cell strains

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

The status of human diploid cell strain MRC-5 as an approved substrate for the production of viral vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

Studies of immunization with living rubella virus. Trials in children with a strain cultured from an aborted fetus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

Serially cultured animal cells for preparation of viral vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

Tumorigenic activity of polyoma virus and SV40 DNAs in newborn rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

Genetic mechanisms of tumor suppression by the human p53 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

Translation factors as effectors of cell growth and tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

Recombinant tissue plasminogen activator: a brief review

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

Strategies for optimising serum-free media

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

Production of monoclonal antibodies in serum free medium

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

Serum-free growth medium for the cultivation of a wide spectrum of mammalian cells in stirred bioreactors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

Making informed choices: medium, serum, and serum-free medium. How to choose the appropriate medium and culture system for the model you wish to create

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

Protein purification: aspects of processes for pharmaceutical products

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

Rational design of purification processes for recombinant proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

Experimental approaches to guarantee minimal risk of potential virus in purified monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

Purification of factor VIII and von Willebrand factor from human plasma by anion-exchange chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2899%2901420-1

7 January 2021

10.1016/S0167-7799(99)01420-1

Identifiers

DOI

1 reference

29 July 2017

1 reference